ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
FDA: Early endpoints and late endpoints suggest a path to global regulatory convergence (Bart et al.)
UK to expand NHS Subscription Pilot! Consultation Period launches
FDA AMDAC – Developing Single-Pathogen agents for P. aeruginosa and A. baumannii
DTR Gram-negative infections: Are new antibiotics making a difference?
The 6 meanings of “Lack of Access” (UNSLAP)
Public meeting on the LPAD Pathway: Post-meeting thoughts (wonkish)
Lancet: 10-20-30 targets to address AMR by 2030
Categories of resistance: MDR, XDR, PDR, UDR, and (new!) DTR
FDA Workshop: Animal Models To Support Antibacterial Development (5 Mar 2020, post-meeting notes)
New mechanisms for antibiotic reimbursement in the United States: CMS’s IPPS FY2020 Final Rule
Two new oral drugs for gonorrhea!
Push! Pull! Push! Pull! / Highlights from Davos 2018
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet